ADVFN Logo

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

0QSS Phaxiam Therapeutics

71.025
0.00 (0.0%)
01 Dec 2023 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Year End 31 December 2022 20152016201720182019202020212022
EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)EUR (€)
Total Revenue 2.93M4.14M3.36M4.45M5.28M3.72M4.18M6.65M
Operating Income -15.5M-22.39M-30.89M-43.62M-64M-68.83M-56.52M-27.15M
Pre Tax Income -15.02M-21.9M-33.53M-38.22M-62.66M-73.3M-53.8M293k
Net Income -15.01M-21.91M-33.53M-38.22M-62.66M-73.3M-53.8M-228k
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) -1.895-2.51-1.869-2.131-3.493-3.655-1.734-0.007
EBIT -15.58M-22.39M-30.89M-43.62M-64.07M-68.83M-56.52M-27.15M
EBITDA -15.21M-21.96M-30.36M-42.82M-59.79M-63.84M-51.14M-22.53M

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: +44 (0) 203 8794 460 | support@advfn.com